# FDA recall D-0261-2024

> **PFIZER** · Class I · drug recall initiated 2023-12-21.

## Product

Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18

## Reason for recall

Presence of particulate matter: glass

## Distribution

Nationwide in the USA, Netherlands and Libya

## Key facts

- **Recall number:** D-0261-2024
- **Recalling firm:** PFIZER
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-12-21
- **Report date:** 2024-01-31

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0261-2024

## Citation

> AI Analytics. FDA recall D-0261-2024. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0261-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*